NSAID-enteropathy and intestinal microbes

Inflammopharmacology. 2021 Feb;29(1):1-4. doi: 10.1007/s10787-020-00766-8. Epub 2020 Oct 15.

Authors

Ingvar Bjarnason¹, K D Rainsford²

Affiliations

¹ Department of Gastroenterology, King's College Hospital, Denmark Hill, London, SE5 9RS, UK. ingvarbjarnason@mac.com.
² Biomedical Research Centre, Sheffield Hallam University, Sheffield, S11WB, UK.

PMID: 33058017
DOI: 10.1007/s10787-020-00766-8

No abstract available

Keywords: Enteropathy; Intestinal microbiome; NSAID; Pathogenesis of NSAID-enteropathy; Small bowel damage.

Publication types

Editorial

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Gastrointestinal Microbiome / drug effects*
Humans
Intestinal Diseases / drug therapy
Intestinal Diseases / microbiology
Intestines / drug effects
Intestines / microbiology

Substances

Anti-Inflammatory Agents, Non-Steroidal